COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Rheumatol Int
; 44(1): 73-80, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38060005
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Diabetes Mellitus, Type 1
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Rheumatol Int
Year:
2024
Document type:
Article
Affiliation country:
India
Country of publication:
Alemania